Pediatric blood & cancer

Keyphrases

Publications

volume 71, number 9, 2024

Aniek Uittenboogaard, Mirjam van de Velde, Lisa van de Heijden, Leah Mukuhi, Niels de Vries, Sandra Langat, Gilbert Olbara, Alwin D R Huitema, Terry A Vik, Gertjan Kaspers, Festus Njuguna
Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study. Pediatric blood & cancer 71 (9) (2024)
Kirk D Wyatt, Natasha Alexander, Gerard D Hills, Wayne H Liang, Stephan Kadauke, Samuel L Volchenboum, Amir Mian, Charles A Phillips
Making sense of artificial intelligence and large language models-including ChatGPT-in pediatric hematology/oncology. Pediatric blood & cancer 71 (9) (2024)
Brett Ells, Zara Forbrigger, Naeem Khan, Anjali A Sharathkumar, Shoshana Revel-Vilk, Neil A Goldenberg, Ketan Kulkarni
Epidemiology of clinically unsuspected venous thromboembolism in children with cancer: A population-based study from Maritimes, Canada. Pediatric blood & cancer 71 (9) (2024)
Amambay Riquelme, Jana Werner, Martin Zimmermann, Hannah von Mersi, Edita Kabíčková, Francesco Ceppi, Jan Foerster, Jasmin Finger, Stephanie Müller, Andishe Attarbaschi, Birgit Burkhardt, Wilhelm Woessmann
Non-Hodgkin lymphoma presenting with spinal cord compression: A population-based analysis of the NHL-BFM study group. Pediatric blood & cancer 71 (9) (2024)
Shilpa Kesari, Carly Barron, Laurie E Cohen, Molly O Regelmann, Tamar G Baer
Dexamethasone swish and spit: A cause of iatrogenic adrenal insufficiency. Pediatric blood & cancer 71 (9) (2024)
Elisabeth T Tracy, Harold Leraas, Lindsay Olson, Robert C Shamberger, Peter F Ehrlich
Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey. Pediatric blood & cancer 71 (9) (2024)
Vivek Mohan, Sachin Jain, Rahul Naithani
Low-dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe-BIRD) in a child with relapsed/refractory B-cell acute lymphoblastic leukemia with TP53 mutation. Pediatric blood & cancer 71 (9) (2024)
Antoine Gourmel, Héloïse Perrault, Marie-Laure Colaiacovo, Louise Laramée, Marieke Rozendaal, Henrique Bittencourt, Caroline Laverdière, Josette Champagne, Sonia Cellot, Lewis B Silverman, Emmanuelle Lemyre, Catalina Maftei, Géraldine Mathonnet, Frédérique Tihy, Marie-Claude Pelland-Marcotte, France Léveillé, Thai Hoa Tran
The impact of comparative genomic hybridization/single-nucleotide polymorphism microarray in risk stratification of pediatric acute lymphoblastic leukemia. Pediatric blood & cancer 71 (9) (2024)
Yusuke Akane, Masaki Yamamoto, Akira Takebayashi, Ryo Hamada, Keita Igarashi, Makoto Emori, Shintaro Sugita, Kohichi Takada, Tadashi Hasegawa, Takeshi Tsugawa
Crizotinib therapy for congenital embryonal rhabdomyosarcoma associated with an ATIC-ALK gene fusion. Pediatric blood & cancer 71 (9) (2024)
Bridget N Murphy, Mary E Keenan-Pfeiffer, Adam Lane, Lori E Crosby, Kathleen E Walsh
Feasibility of a clinic-based, multicomponent hydroxyurea adherence intervention for adolescents and young adults with sickle cell disease. Pediatric blood & cancer 71 (9) (2024)
Milica Miladinovic, Dirk Reinhardt, Henrik Hasle, Bianca F Goemans, Masanori Yoshida, Johann K Hitzler, Jan-Henning Klusmann
Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndrome. Pediatric blood & cancer 71 (9) (2024)
Lena E Winestone, Jennifer J Wilkes, Diane Puccetti, Theresa H M Keegan, Henry J Henk, Jeffrey McPheeters, Justine M Kahn, Jill Ginsberg, Samantha Wong, Sage Timberline, Marcio Malogolowkin, Brad H Pollock, Elysia M Alvarez
Time to diagnosis among young patients with cancer. Pediatric blood & cancer 71 (9) (2024)
Charles Yin, Elona Turley, Joel Livingston
Identification of a novel MYH9-related disease-associated mutation with multiple faintly staining Döhle-like bodies. Pediatric blood & cancer 71 (9) (2024)
Rachel D Harris, Olga A Taylor, Kimberly P Raghubar, Maria Monica J Gramatges, Mark C Zobeck, M Monica Gramatges, Karen R Rabin, Michael E Scheurer, Austin L Brown
Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function. Pediatric blood & cancer 71 (9) (2024)
Meghan Davitt, Rachel Offenbacher, Michelle A Lee, David M Loeb, Deepa Manwani, William Beauregard Mitchell, Daniel A Weiser
Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition? Pediatric blood & cancer 71 (9) (2024)
Paige Reilly, Carlos Murga-Zamalloa, Batool H Husain, Alex Javois, Peter Varga, Naveen Imran, Martha Menchaca, Mary Lou Schmidt
Fibrin-associated diffuse large B-cell lymphoma in a pediatric patient. Pediatric blood & cancer 71 (9) (2024)
Francesca Gigola, Francesco Morini, Giorgia Libro, Antonino Morabito, Chiara Grimaldi
Congenital hepatoblastoma: Expanding knowledge, improving outcomes. Pediatric blood & cancer 71 (9) (2024)
Marzia Ognibene, Stefano Parodi, Loredana Amoroso, Federico Zara, Annalisa Pezzolo
Overexpression of H2AFX gene in neuroblastoma is associated with worse prognosis. Pediatric blood & cancer 71 (9) (2024)
Lise Marie Krogh, Anne Nissen, Sarah Weischendorff, Bolette Hartmann, Jesper Løvind Andersen, Jens Juul Holst, Kaspar Sørensen, Martin Kaj Fridh, Abigail Louise Mackey, Klaus Müller
Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training. Pediatric blood & cancer 71 (9) (2024)
Ludmila Papusha, Margarita Zaytseva, Maria Senchenko, Agunda Sanakoeva, Agnesa Panferova, Tatiana Sharanda, Irina Vilesova, Alexandra Tarakanova, Ekaterina Salnikova, Natalia Usman, Anton Artemov, Alexander Karachunskiy, Alexey Maschan, Eugene I Hwang, Roger J Packer, Galina Novichkova, Alexander E Druy
Cabozantinib in children with recurrent diffuse gliomas. Pediatric blood & cancer 71 (9) (2024)
Jasmine Smith, Sara Meehan, Sara Helmig
Complete remission of EWSR1-KLF15 myoepithelial carcinoma of the soft tissue following pazopanib monotherapy. Pediatric blood & cancer 71 (9) (2024)
Ariel Nash, William Weirda, Karen Albritton, Branko Cuglievan, Miriam B Garcia, David C McCall, Cesar Nunez, Amber Gibson
Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy. Pediatric blood & cancer 71 (9) (2024)
Hutton Chapman, Paulo S Ntemi, Mwitasrobert Gisiri, Lavanya Vasudevan, Heronima J Kashaigili, Kristin M Schroeder
Retrospective analysis of pediatric patients with Burkitt lymphoma treated in Tanzania following the implementation of the 2016 National Treatment Guidelines: Poor outcomes to current standard-of-care therapy. Pediatric blood & cancer 71 (9) (2024)
Angela Steineck, Sara K Silbert, Kallie Palm, Jordyn Nepper, Dagny Vaughn, Kelly Shipman, Haneen Shalabi, Lori S Wiener, Liam Comiskey, Jennifer M Knight, Deena Levine
Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T-cell therapy in pediatrics. Pediatric blood & cancer 71 (9) (2024)
Jerry Li, Lin Swan, Nickens Dana, Frank M Balis, Emily G Greengard, Xu Huiping
Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers. Pediatric blood & cancer 71 (9) (2024)
Ashna Hudani, Kahaki Kimani, Lucy Njambi, Helen Dimaras
Navigating familial retinoblastoma in Kenya: A mother's journey. Pediatric blood & cancer 71 (9) (2024)
Juwon Yim, Afrin Jahan, Nikolay Braykov, Gary M Woods
Enoxaparin treatment dosing for venous thromboembolism in pediatric patients with obesity. Pediatric blood & cancer 71 (9) (2024)
Eun Seop Seo, Ji Won Lee, Hee Won Cho, Hee Young Ju, Young Seok Cho, Sanghoon Lee, Seung Hwan Moon, Keon Hee Yoo, Do Hoon Lim, Ki Woong Sung
Response-adapted consolidation therapy strategy for patients with metastatic high-risk neuroblastoma: Results of the SMC NB-2014 study. Pediatric blood & cancer 71 (9) (2024)
Christy M Lucas, Molly C Mack, Jill Majeski, Scott H Maurer
Exploring perceptions of inpatient hospital attire in children with cancer. Pediatric blood & cancer 71 (9) (2024)
Serafin Castellano-Damaso, Felisa Vazquez-Gomez, Marta Perez-Somarriba, Mauricio Sanchez-Salazar, Álvaro Lassaleta-Atienza
Artificial intelligence chatbots: Are they a reliable source for patients and families in pediatric neuro-oncology? Pediatric blood & cancer 71 (9) (2024)
Roa Harb, Tatiana C Coverdell, Haneen Shalabi, Nirali N Shah
Diagnostic pitfalls in assessment of ferritin following CAR-T-cell therapy: Understanding the hook effect. Pediatric blood & cancer 71 (9) (2024)
Andrea Vilaplana, Mariona Morell, Lorena Valero-Arrese, Lynley V Marshall, Anna Saló, Tracey Crowe, Laura Romero, Teresa de Rojas, Fernando Carceller, Lucas Moreno
Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer. Pediatric blood & cancer 71 (9) (2024)
Brandon Buxton, Katharina Elliott, Carla Schwalm
Direct oral anticoagulant use in hospitalized pediatric patients: Insights from nationwide data. Pediatric blood & cancer 71 (9) (2024)
Lauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, Chaya S Moskowitz, Kimberly Bogardus, Zoltan Antal, Suzanne L Wolden, Michael P LaQuaglia, Ellen M Basu, Fiorella Iglesias Cardenas, Kim Kramer, Brian H Kushner, Nai-Kong V Cheung, Shakeel Modak, Danielle Novetsky Friedman
Ovarian function in female survivors of high-risk neuroblastoma. Pediatric blood & cancer 71 (9) (2024)
Kemar V Prussien, Haley L Faust, Lori E Crosby, Kim Smith-Whitley, Lamia P Barakat, Lisa A Schwartz
The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study. Pediatric blood & cancer 71 (9) (2024)
Beth Effeney, Andrew Pullar, Julie Burbery, Catriona Hargrave, Carole Brady
Dose to organs at risk for total body irradiation: Single-institution data using the modulated arc total body irradiation technique. Pediatric blood & cancer 71 (9) (2024)
Kristine A Karkoska, Jahnavi Gollamudi, Russell P Sawyer, Daniel Woo, Hyacinth I Hyacinth
Quantifying dilated perivascular spaces in children with sickle cell disease. Pediatric blood & cancer 71 (9) (2024)
Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, Tomoko Kawai, Kentaro Ohki, Yusuke Hara, Genki Yamato, Reo Tanoshima, Masanori Yoshida, Akira Shimada, Keizo Horibe, Souichi Adachi, Takashi Taga, Akio Tawa, Yasuhide Hayashi, Shuichi Ito, Norio Shiba
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Pediatric blood & cancer 71 (9) (2024)
Lauren E Kushner, Hayden T Schwenk, FeiFei Qin, Derek Boothroyd, Catherine Aftandilian
Application of cell-free DNA fungal polymerase chain reaction for invasive fungal disease evaluation in pediatric oncology and stem cell transplant patients. Pediatric blood & cancer 71 (9) (2024)
Hilde Hylland Uhlving, Lena Specht, Tania Nicole Masmas, Mogens Bernsdorf, Marianne Ifversen
Late effects following HSCT for childhood ALL: A national single-center study using three different modalities of delivery of total body irradiation. Pediatric blood & cancer 71 (9) (2024)
Mitchell Clingo, Daniel Bustamante, Benjamin Carcamo, Steven Ross, Ziyad Makoshi, Chetan Moorthy, Simone M Chang
Hypertrophic pachymeningitis as an unusual presentation of a patient with SLC29A3 spectrum disorder: Considering the use of next-generation sequencing. Pediatric blood & cancer 71 (9) (2024)
Ya-Hsuan Chang, Chih-Hsiang Yu, Meng-Yao Lu, Shiann-Tarng Jou, Chien-Yu Lin, Kai-Hsin Lin, Hsiu-Hao Chang, Yu-Ling Ni, Shu-Wei Chou, Kuan-Yin Ko, Dong-Tsamn Lin, Wen-Ming Hsu, Hsuan-Yu Chen, Yung-Li Yang
Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma. Pediatric blood & cancer 71 (9) (2024)
Robyn T Cohen, Shana A B Burrowes, Christopher J Williams, Caitlin M Neri, Elizabeth S Klings, Kayla C Jones, Allan J Walkey, Mari-Lynn Drainoni
SNAP: Supportive non-invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team. Pediatric blood & cancer 71 (9) (2024)
Shaikha Alqahtani, Karen DiValerio Gibbs, Natalie A Montanez, Kate J Krause, C Heleen van Ommen, Lakshmi V Srivaths
Direct oral anticoagulant therapy in adolescent venous thromboembolism: A systematic review. Pediatric blood & cancer 71 (9) (2024)
Christina J VanderPluym, Ryan Kobayashi
Leveling the playing field: The role of level-based dosing in pediatric anticoagulation management. Pediatric blood & cancer 71 (9) (2024)
Rui Wang, Xiao-Hong Ma, Ze-Zhen Qin, Xin-Xuan Hu, Zhi-Yang Mo, Ya-Ye Zhao, Ping Zheng, Qiao-Shan Lu, Qiao Li, Xian-Yan Tang
Global, regional, and national burden of thalassemia during 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019. Pediatric blood & cancer 71 (9) (2024)
Justyna Miśkiewicz-Bujna, Izabella Miśkiewicz-Migoń, Marta Kozłowska, Katarzyna Bąbol-Pokora, Ninela Irga-Jaworska, Wojciech Mlynarski, Krzyzstof Kalwak, Marek Ussowicz
Successful hematopoietic stem cell transplantation in MYH9-related congenital thrombocytopenia. Pediatric blood & cancer 71 (9) (2024)
Amber K Weiner, Antonia Palmer, Melanie Frost Moll, Gavin Lindberg, Kevin Reidy, Sharon J Diskin, Crystal L Mackall, John M Maris, Patrick J Sullivan
Advancing childhood cancer research through young investigator and advocate collaboration. Pediatric blood & cancer 71 (9) (2024)
Chan-Juan Wang, Ting Zhu, Chen-Zi Zhao, Hua Cui, Dong Wang, Zi-Jing Zhao, Xiao-Tong Huang, Hua-Lin Li, Fei-Fei Liu, Rui Zhang, Zhi-Gang Li, Lei Cui
BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy. Pediatric blood & cancer 71 (9) (2024)
Juwon Yim, Afrin Jahan, Nikolay Braykov, Nina D Murphy, Gary M Woods
Enoxaparin thromboprophylaxis in hospitalized obese pediatric patients. Pediatric blood & cancer 71 (9) (2024)